Jennifer K Simpson, Ph.D., MSN, CRNP
President and Chief Executive Officer

Dr. Simpson joined Panbela as President and Chief Executive Officer in July of 2020 and was also appointed as a Director at that time. She brings to the Company more than 12 years’ experience in pharmaceutical executive leadership, global marketing and product commercialization. Most recently Dr. Simpson was the CEO of Delcath (Nasdaq:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancer.

Read more

Susan Horvath
Vice President and Chief Financial Officer

Ms. Horvath has held both finance and operating positions within pharmaceutical, healthcare and consumer organizations.  In addition to her position with the Company, Ms. Horvath sits on the board of directors and provides financial consulting services for Photonic Pharma, LLC, a privately held company focused on efficiencies in early stage drug discovery. Most recently she served as Chief Financial Officer of Eyebobs, LLC, a private company focused on the reading glasses industry.

Read more

Thomas X. Neenan, Ph.D.
Co-Founder and Chief Scientific Officer

Dr. Neenan is an entrepreneur and scientist with extensive chemistry and business development executive experience with AT&T Bell Labs, Geltex, Genzyme, Warwick Effect Polymers, and Proxy Biomedical. Prior to co-founding Panbela, he was the founding CEO and Chief Technology Officer at Sideris Pharmaceuticals Inc, raising $32M in equity financing.

Read more

Suzanne Gagnon, M.D.
Chief Medical Officer

Dr. Gagnon has served as Chief Medical Officer and as a Director of Panbela since September 2015. She originally joined the Company as 2014 as its Lead Clinical Consultant. Dr. Gagnon has been the President of Gagnon Consulting LLC since July 2014, providing consulting expertise on medical, safety and regulatory matters related to clinical drug development.

Read more

Rachel Bragg, MPH
Vice President of Clinical Development

Mrs. Bragg joined Panbela as Vice President of Clinical Development in June of 2021.  She brings to the company ~20 years’ experience in pharmaceutical research which spans the biotech, pharma and CRO markets.  Most recently Mrs. Bragg was the Therapeutic Area Head of Hematology Oncology for Product Delivery at PPD focusing on global program and trial strategy for various indications within hematology and oncology drug development.

Read more

Tammy Groene
Vice President of Operations

Since April 2012, Ms. Groene has provided operational management and administrative support to the Panbela team. Prior to joining Panbela Therapeutics, Inc., Ms. Groene worked for MGI Pharma, Inc. as the Executive Assistant to the Chief Medical Officer then transitioned into the Marketing Department. Ms. Groene earned her Bachelor of Science degree from St. Cloud State University in St. Cloud, Minnesota.

Anthony L. Kiorpes, Ph.D., DVM
Toxicology Consultant

Andy Kiorpes is a graduate of Columbia University (BA Biology, 1970), the University of Wisconsin-Madison (MS Veterinary Science, 1974; PhD Physiology, 1977) Kansas State University (DVM, 1982), and the University of Arkansas (MBA, 1999). He has over 22 years of experience as a toxicologist working in food, pharmaceutical, and medical device development and safety.

Read more

Michael Walker, M.D.
Pancreatic Research Consultant

Dr. Michael Walker obtained his BS (Biochemistry) and MD degrees from the University of Minnesota. He completed his General Surgery residency and a 2-year American Cancer Society clinical and research fellowship at UCLA, focusing on pancreatic islets and their molecular physiology. Before joining Panbela, he practiced General Surgery in Minnesota.

Read more

Kristen Flaharty, PharmD
Pharmacology Consultant

Dr. Kristen Flaharty, a board certified Clinical Pharmacologist, has been a consultant to the pharmaceutical industry, for the past 20 years, primarily involved in clinical pharmacology and regulatory aspects of pharmaceutical development. Dr. Flaharty has presented clinical development plans and pre-registration packages at FDA’s Center for Drug Evaluation and Research on behalf of sponsors…

Read more